MIAN, CATERINA
 Distribuzione geografica
Continente #
NA - Nord America 9.159
EU - Europa 1.413
AS - Asia 817
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
AF - Africa 2
Totale 11.405
Nazione #
US - Stati Uniti d'America 9.140
CN - Cina 664
IT - Italia 536
SE - Svezia 238
DE - Germania 177
FI - Finlandia 172
GB - Regno Unito 117
VN - Vietnam 110
UA - Ucraina 52
FR - Francia 38
IE - Irlanda 29
CA - Canada 19
GR - Grecia 14
HK - Hong Kong 14
IN - India 14
NL - Olanda 10
TR - Turchia 9
BG - Bulgaria 8
RU - Federazione Russa 6
BE - Belgio 4
EU - Europa 4
BR - Brasile 3
PL - Polonia 3
SI - Slovenia 3
AU - Australia 2
CZ - Repubblica Ceca 2
JP - Giappone 2
NZ - Nuova Zelanda 2
PE - Perù 2
RO - Romania 2
SG - Singapore 2
TZ - Tanzania 2
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
IQ - Iraq 1
PH - Filippine 1
Totale 11.405
Città #
Fairfield 1.744
Woodbridge 943
Ashburn 760
Chandler 740
Houston 700
Cambridge 622
Seattle 617
Ann Arbor 597
Wilmington 564
Beijing 200
Jacksonville 200
Princeton 183
San Diego 163
Padova 159
Medford 114
Des Moines 113
Dong Ket 109
Helsinki 84
Nanjing 77
Boardman 66
Roxbury 64
Columbus 38
Guangzhou 37
Jinan 32
London 30
Dublin 29
New York 28
Shenyang 28
Falls Church 27
Milan 26
Nanchang 26
Ogden 24
Changsha 22
Hebei 21
Norwalk 20
Tianjin 19
Jiaxing 18
Redwood City 17
Kunming 15
Washington 15
Hong Kong 14
Los Angeles 14
Rome 14
Hefei 12
Kharkiv 12
Kilburn 12
Munich 11
Borås 9
Zhengzhou 9
Fuzhou 8
North York 8
Phoenix 8
Sofia 8
Taizhou 8
Dearborn 7
Mestre 7
Tappahannock 7
Bologna 6
Chiswick 6
Haikou 6
Hounslow 6
Paris 6
Turin 6
Vigonza 6
Aprilia 5
Bari 5
Florence 5
Ningbo 5
Prescot 5
Rockville 5
Taiyuan 5
Hangzhou 4
Venice 4
Acton 3
Berlin 3
Castelbellino 3
Catania 3
Cesiomaggiore 3
Chengdu 3
Detroit 3
Formia 3
Frankfurt am Main 3
Indiana 3
Marghera 3
Montebello Vicentino 3
Montréal 3
Mumbai 3
Nürnberg 3
Philadelphia 3
Pune 3
Tekirdağ 3
Temecula 3
Toronto 3
Ankara 2
Ardea 2
Auckland 2
Brentwood 2
Cagliari 2
Camisano 2
Casale Monferrato 2
Totale 9.618
Nome #
L’elastosonografia come sostituto dell’esame citologico nei nodi soffici 266
0C22 men2A da mutazione di ret C6009S. descrizione di una grande famiglia 262
PROGNOSTIC SIGNIFICANCE OF TERT PROMOTER AND BRAF MUTATIONS IN TIR-4 AND TIR-5 THYROID CYTOLOGY 228
The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes 194
BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. 185
Overexpression of L-Type amino acid transporter 1 (LAT1) and 2 (LAT2): Novel markers of neuroendocrine tumors 148
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 142
BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience 142
Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients 138
The PDCD4/miR-21 pathway in medullary thyroid carcinoma. 134
Prevalence, Tumorigenic Role, and Biochemical Implications of Rare BRAF Alterations. 133
Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines 131
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 125
Functional Significance of the Novel H-RAS Gene Mutation M72I in a Patient with Medullary Thyroid Cancer. 119
Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience 115
MEN2A/FMTC AND THE V804M RET MUTATION 112
Iodine status in schoolchildren living in northeast italy:the importance of iodized-salt use and milk consumption. 110
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells 109
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake 107
Sodium/iodide symporter in thyroid cancer 106
Calcitonin measurement and immunoassay interference: A case report and literature review 106
Iodine status from childhood to adulthood in females living in North-East Italy: Iodine deficiency is still an issue. 104
Retinal photoreceptor functions are compromised in patients with resistance to thyroid hormone syndrome (RTHβ) 104
EF24 (a curcumin analog) and ZSTK474 emphasizes the effect of cabozantinib in medullary thyroid cancer 104
Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening 104
Efficacy of educational intervention to improve awareness of the importance of iodine, use of iodized salt, and dietary iodine intake in northeastern Italian schoolchildren 104
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review. 103
BRAF V600E confers male sex disease-specific mortality risk in patients with papillary thyroid cancer 101
Association of primary aldosteronism with chronic thyroiditis 100
Normal values for thyroid ultrasonography, goiter prevalence and urinary iodine concentration in schoolchildren of the Veneto Region, Italy 99
microRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. 99
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma 98
Bone turnover markers, BMD and TBS after short-term, high-dose glucocorticoid therapy in patients with Graves’ orbitopathy: a small prospective pilot study 97
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants 96
PTH: Redefining Reference Ranges in a Healthy Population-The Role of Interfering Factors and the Type of Laboratory Assay 95
INFLUENCE OF PHYSIOLOGICAL DIETARY SELENIUM SUPPLEMENTATION ON THE NATURAL COURSEOF AUTOIMMUNE THYROIDITIS 94
RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series 94
The effects of iodine supplementation in pregnancy on iodine status, thyroglobulin levels and thyroid function parameters: Results from a randomized controlled clinical trial in a mild-to-moderate iodine deficiency area 94
Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience. 93
Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors. 93
Frequency and significance of Ras, Tert promoter, and Braf mutations in cytologically indeterminate thyroid nodules: A monocentric case series at a tertiary-level Endocrinology unit 92
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. 92
Biological effects of EF24, a curcumin derivative, alone or combined with mitotane in adrenocortical tumor cell lines 92
Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas 91
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line 91
The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer 91
Familial nonsyndromic pheochromocytoma. 89
BRAF in primary and recurrent papillary thyroid cancers the relationship with (131) 1 and 2 [(18)F] fluoro-2-deoxy-D-glucose uptake ability. 89
Restricted intraindividual urinary iodine concentration variability in nonfasting subjects 89
Milk represents an important source of iodine in schoolchildren of the Veneto region, Italy 88
Deregulated expression of aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients. 88
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 88
Sodium iodide symporter and pendrin expression in human thyroid tissues 87
Follicular Thyroid Carcinoma with Metastases to the Pituitary Causing Pituitary Insufficiency. 86
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer. 86
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. 85
Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario 84
A Multiomodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients 83
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. 83
Deregulated expression of VHL mRNA variants in papillary thyroid cancer 83
A Novel Thyroid Hormone Receptor Beta Mutation (G357R) in a Family with Resistance to Thyroid Hormone Beta: Extending the Borders of the "Hot" Region in the THRB Gene 83
HEX, PAX-8 and TTF-1 gene expression in human thyroid tissues: a comparative analysis with other genes involved in iodide metabolism 82
The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways. 81
Selenium Supplementation, Body Mass Composition, and Leptin Levels in Patients with Obesity on a Balanced Mildly Hypocaloric Diet: A Pilot Study 80
Anticancer Effects of Wild Mountain Mentha longifolia Extract in Adrenocortical Tumor Cell Models 78
PDCD4 expression in thyroid neoplasia 76
Expression of pendrin and the Pendred Syndrome (PDS) gene in human thyroid tissues 76
Unique Case of a Large Indolent Medullary Thyroid Carcinoma: Time to Reconsider the Medullary Thyroid Adenoma Entity? 76
The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells. 75
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. 75
Frequent TSH Receptor Genetic Alterations with Variable Signaling Impairment in a Large Series of Children with Nonautoimmune Isolated Hyperthyrotropinemia. 74
High Expression of the Urokinase Plasminogen Activator and Its Cognate Receptor Associates with Advanced Stages and Reduced Disease-Free Interval in Papillary Thyroid Carcinoma. 74
Insulin autoimmune syndrome: from diagnosis to clinical management 74
Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. 74
Galectin-3 cytotest in thyroid follicular neoplasia: a prospective,monoinstitutional study 73
MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical–pathological features and outcome 73
Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation 72
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 72
Amiodarone-induced thyrotoxicosis: Differential diagnosis using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR) 72
Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period 72
Medullary thyroid carcinoma: Clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986 71
Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety. 70
Evidence of a low prevalence of a ras mutations in a large medullary thyroid cancer series. 70
Na+/I- symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues 70
Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer 70
Comparison of Calcium and Pentagastrin Tests for the Diagnosis and Follow-Up of Medullary Thyroid Cancer 69
Comparison Of The Diagnostic Accuracy Of Combined Elastosonography And Braf Analysis Versus Cytology And Ultrasonography For Thyroid Nodule Suspected Of Malignancy. 69
Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation. 69
Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations 69
Thyroid node assessment: how can we avoid unnecessary surgical procedures? 68
In papillary thyroid carcinoma BRAF(V600E) is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval. 68
CTLA-4 and PD-1 ligand gene expression in epithelial thyroid cancers 68
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study 68
The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma. 67
The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations 66
Galectin-3 expression in thyroid fine needle cytology (t-FNAC) uncertain cases: Validation of molecular markers and technology innovation 63
Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment 63
RET codon 609 mutations: a contribution for better clinical managing 62
PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues 62
First proof of association between autoimmune polyglandular syndrome and multiple endocrine neoplasia in humans 62
Totale 9.601
Categoria #
all - tutte 41.563
article - articoli 39.662
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 316
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019634 0 0 0 0 0 0 0 0 0 0 300 334
2019/20202.805 263 127 89 293 263 188 295 298 386 302 161 140
2020/20212.149 103 190 130 166 58 147 98 180 261 337 207 272
2021/20222.126 68 223 218 172 168 129 145 219 144 56 176 408
2022/20231.558 317 202 14 204 217 218 17 88 169 23 69 20
2023/2024912 41 106 159 91 101 109 122 63 61 56 3 0
Totale 11.568